Division of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
J Nutr Biochem. 2024 May;127:109604. doi: 10.1016/j.jnutbio.2024.109604. Epub 2024 Feb 18.
Recent human and animal studies have delineated hypertension can develop in the earliest stage of life. A lack or excess of particular nutrients in the maternal diet may impact the expression of genes associated with BP, leading to an increased risk of hypertension in adulthood. Modulations in gene expression could be caused by epigenetic mechanisms through aberrant DNA methylation, histone modification, and microRNAs (miRNAs). Several molecular mechanisms for the developmental programming of hypertension, including oxidative stress, dysregulated nutrient-sensing signal, aberrant renin-angiotensin system, and dysbiotic gut microbiota have been associated with epigenetic programming. Conversely, maternal nutritional interventions such as amino acids, melatonin, polyphenols, resveratrol or short chain fatty acids may work as epigenetic modifiers to trigger protective epigenetic modifications and prevent offspring hypertension. We present a current perspective of maternal malnutrition that can cause fetal programming and the potential of epigenetic mechanisms lead to offspring hypertension. We also discuss the opportunities of dietary nutrients or nutraceuticals as epigenetic modifiers to counteract those adverse programming actions for hypertension prevention. The extent to which aberrant epigenetic changes can be reprogrammed or reversed by maternal dietary interventions in order to prevent human hypertension remains to be established. Continued research is necessary to evaluate the interaction between maternal malnutrition and epigenetic programming, as well as a greater focus on nutritional interventions for hypertension prevention towards their use in clinical translation.
最近的人类和动物研究表明,高血压可能在生命的早期阶段就会出现。母体饮食中缺乏或过量的某些营养物质可能会影响与血压相关的基因表达,从而增加成年后患高血压的风险。基因表达的调节可能是由表观遗传机制引起的,包括异常的 DNA 甲基化、组蛋白修饰和 microRNAs(miRNAs)。几种高血压发育编程的分子机制,包括氧化应激、营养感应信号失调、异常肾素-血管紧张素系统和肠道微生物失调,都与表观遗传编程有关。相反,母体营养干预,如氨基酸、褪黑素、多酚、白藜芦醇或短链脂肪酸,可能作为表观遗传修饰物发挥作用,引发保护性表观遗传修饰,预防后代高血压。我们提出了母体营养不良导致胎儿编程的最新观点,以及表观遗传机制导致后代高血压的潜在可能性。我们还讨论了膳食营养素或营养保健品作为表观遗传修饰物的机会,以对抗那些预防高血压的不利编程作用。为了预防人类高血压,母体膳食干预纠正或逆转异常表观遗传变化的程度仍有待确定。需要继续研究,以评估母体营养不良和表观遗传编程之间的相互作用,以及更加关注预防高血压的营养干预,以促进其在临床转化中的应用。
J Endocrinol. 2019-7-1
Biol Trace Elem Res. 2025-6-19
Front Physiol. 2025-4-28
Int J Mol Sci. 2025-1-22